DAVID LEE JOHNSON
CIK 1733883 · Chief Operating Officer · last filed 2026-02-25
DAVID LEE JOHNSON is a Chief Operating Officer who has filed 31 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing shows the insider sold $108.3K of VERA on Feb 25, 2026. Across all open-market trades the lifetime net is −$108.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.57M
3
31
-$108.3K
Holdings By Company
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-25 | VERA | Sell (S) | −2,579 | -$108.3K | EDGAR |
| 2026-02-20 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2026-02-06 | VERA | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-02-21 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | VERA | Grant (A) | +26,900 | $0 | EDGAR |
| 2024-07-03 | VERA | Grant (A) | — | $0 | EDGAR |
| 2024-02-22 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2023-02-23 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | −56,384 | $0 | EDGAR |
| 2022-09-06 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | +3,233 | -$134.1K | EDGAR |